EENT · PANCE / PANRE

Acute Bacterial Rhinosinusitis (ABRS)

Bacterial infection of paranasal sinuses lasting <4 weeks, typically following viral URI.

Also known as: acute bacterial sinusitis, ABRS, acute rhinosinusitis, sinus infection

Overview

Acute bacterial rhinosinusitis (ABRS) is symptomatic inflammation of the paranasal sinuses lasting <4 weeks, distinguished from viral rhinosinusitis by duration ≥10 days without improvement, worsening after initial improvement ('double-sickening'), or severe onset with high fever and purulent discharge ≥3-4 consecutive days.

Epidemiology

Acute rhinosinusitis affects ~12% of US adults annually. Only 0.5-2% of viral rhinosinusitis cases progress to ABRS, yet antibiotics are over-prescribed. Maxillary sinus most commonly affected, followed by ethmoid, frontal, then sphenoid.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Bacterial Rhinosinusitis (ABRS) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Preceding viral URI (vast majority)
  • Allergic rhinitis
  • Anatomic obstruction (deviated septum, polyps, concha bullosa)
  • Dental infection (maxillary sinus floor adjacent to molar roots)
  • Smoking, air pollutants
  • Immunodeficiency (HIV, hypogammaglobulinemia)
  • Cystic fibrosis, primary ciliary dyskinesia
  • Diabetes (mucormycosis risk)

Pathophysiology

Viral URI → mucosal edema and ciliary dysfunction obstruct sinus ostia → impaired mucociliary clearance and stagnant secretions → bacterial overgrowth. Dominant pathogens: Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis. Staphylococcus aureus and anaerobes in chronic/severe cases. Odontogenic etiology → mixed oral flora.

Clinical presentation

Symptoms

  • Purulent nasal discharge (anterior or posterior)
  • Nasal obstruction or congestion
  • Facial pain/pressure, worsened by leaning forward or Valsalva
  • Fever (suggests bacterial if persistent and high)
  • Hyposmia or anosmia
  • Dental pain (maxillary), headache, ear fullness, cough

Signs / physical exam

  • Tenderness over involved sinus on palpation
  • Purulent discharge on anterior rhinoscopy or posterior pharyngeal wall
  • Erythema/edema of nasal mucosa
  • Periorbital edema or erythema → orbital complication
  • Cranial neuropathy or altered mental status → intracranial complication

Classic findings

Persistent ≥10-day URI with purulent discharge, facial pressure worse on bending forward, and unilateral maxillary tenderness.

Differential diagnosis

  • Viral rhinosinusitis — Symptoms <10 days, peak at days 3-6 then improve; supportive care; antibiotics not indicated
  • Allergic rhinitis with sinus congestion — Itch, sneezing, clear discharge, atopic history, no fever or facial pain; intranasal corticosteroid
  • Chronic rhinosinusitis — Symptoms ≥12 weeks; nasal endoscopy shows polyps or purulence; CT confirms mucosal disease
  • Dental abscess — Maxillary tooth pain with percussion, periapical lucency on dental imaging; treat underlying tooth
  • Migraine or tension headache — Recurrent headache with photophobia/phonophobia or scalp tension; no purulent discharge or fever
  • Invasive fungal sinusitis (mucormycosis) — Immunocompromised or poorly controlled diabetic with rapid facial pain, black eschar on turbinate or palate, cranial neuropathies; emergent ENT/surgical debridement + IV amphotericin B
  • Nasal foreign body — Unilateral purulent foul discharge in a child
  • Trigeminal neuralgia — Lancinating facial pain triggered by light touch; no purulent discharge

Diagnostic workup

Diagnostic criteria

IDSA 2012 / AAO-HNS 2015 — ABRS if ANY of: (1) symptoms ≥10 days without improvement, (2) severe symptoms — purulent discharge or facial pain with fever ≥39°C (102°F) for ≥3-4 consecutive days at illness onset, or (3) 'double-sickening' — new fever, headache, or increased nasal discharge after a viral URI that had begun improving.

Labs

  • ABRS is a clinical diagnosis — no routine labs
  • Consider CBC, blood cultures if complications suspected
  • Sinus aspirate culture (otolaryngologist) reserved for treatment failure, immunocompromised, or complicated disease

Imaging

  • Not routinely indicated in uncomplicated ABRS
  • CT sinus without contrast if complications suspected, treatment failure, recurrent disease, or surgical planning
  • CT or MRI with contrast for orbital cellulitis, cavernous sinus thrombosis, brain abscess
  • Plain sinus films and ultrasound have largely been abandoned

Diagnostic algorithm

flowchart TD
  A[URI / sinus symptoms] --> B{Symptom duration<br/>and pattern}
  B -->|<10 days, improving| C[Viral rhinosinusitis<br/>Supportive care]
  B -->|≥10 days no improvement| D[ABRS]
  B -->|Severe onset ≥3-4 d<br/>T≥39 + purulent| D
  B -->|Double-sickening<br/>worse after improvement| D
  D --> E{Adult<br/>uncomplicated?}
  E -->|Yes| F[Option:<br/>watchful waiting 7 d<br/>OR amox-clav]
  E -->|No / risk factors| G[High-dose amox-clav<br/>5-10 days]
  F --> H{Improved?}
  G --> H
  H -->|Yes| I[Complete course]
  H -->|No at 72 h| J[Switch antibiotic<br/>± CT sinus<br/>± ENT referral]
  D --> K{Red flags?<br/>Orbital/intracranial/<br/>immunocompromised}
  K -->|Yes| L[Urgent CT/MRI<br/>IV antibiotics<br/>ENT/Ophtho]
Diagnosis and management algorithm for acute bacterial rhinosinusitis.

Treatment

First-line

  • Symptomatic care for ALL: saline nasal irrigation, intranasal corticosteroid (fluticasone, mometasone), analgesics (acetaminophen, NSAIDs), adequate hydration, oral or topical decongestant (pseudoephedrine or oxymetazoline ≤5 days)
  • Watchful waiting × 7 days for uncomplicated ABRS in adults (AAO-HNS option) if reliable follow-up
  • First-line antibiotic: amoxicillin-clavulanate 500/125 mg TID or 875/125 mg BID × 5-10 days (adults); 45 mg/kg/day amoxicillin component for children — IDSA recommends amox-clav OVER amoxicillin alone due to rising H. influenzae beta-lactamase rates
  • High-dose amoxicillin-clavulanate (2 g BID adults; 90 mg/kg/day amoxicillin component children) for: severe infection, immunocompromised, recent antibiotic use, age <2 or >65, daycare, prior hospitalization, region with >10% PCN-resistant S. pneumoniae

Second-line / adjunct

  • Penicillin allergy (non-anaphylactic): doxycycline (adults), or cefuroxime/cefpodoxime/cefdinir
  • Severe penicillin allergy: doxycycline OR levofloxacin/moxifloxacin (reserve fluoroquinolones — FDA boxed warnings)
  • Treatment failure at 72 h: switch to higher-dose amox-clav, doxycycline, or levofloxacin; consider CT and ENT referral
  • Avoid macrolides (azithromycin, clarithromycin) and TMP-SMX as monotherapy due to high pneumococcal resistance
  • Refer to ENT for: orbital/intracranial complications, recurrent ABRS (≥4 episodes/year), anatomic abnormality, immunocompromised

Complications

  • Orbital cellulitis or abscess (especially ethmoid sinusitis in children) — proptosis, ophthalmoplegia, vision loss
  • Subperiosteal abscess
  • Cavernous sinus thrombosis — bilateral CN III/IV/VI palsies, proptosis, fever, altered mental status
  • Pott puffy tumor — frontal sinusitis with osteomyelitis and forehead subperiosteal abscess
  • Meningitis, epidural/subdural empyema, brain abscess
  • Invasive fungal sinusitis in immunocompromised — mucormycosis, aspergillosis
  • Progression to chronic rhinosinusitis

PANCE pearls

  • Distinguishing viral from bacterial sinusitis: duration ≥10 days, double-sickening, or severe high-fever onset with purulent discharge ≥3-4 days.
  • IDSA 2012 recommends amoxicillin-clavulanate over amoxicillin alone — most boards updated to this answer.
  • Avoid macrolides and TMP-SMX as monotherapy — >25% pneumococcal resistance.
  • Periorbital swelling + decreased EOM + proptosis = orbital cellulitis → IV antibiotics + CT + ophthalmology/ENT.
  • Black necrotic eschar on palate or turbinates in a diabetic or immunocompromised patient = mucormycosis — emergent surgical debridement and IV amphotericin B.
  • Intranasal corticosteroids improve symptoms in ABRS as adjunct therapy.

References

  • IDSA 2012 — Chow AW et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis. Clin Infect Dis 2012;54(8):e72-e112
  • AAO-HNS 2015 — Rosenfeld RM et al. Clinical Practice Guideline (Update): Adult Sinusitis. Otolaryngol Head Neck Surg 2015;152(2S):S1-S39
  • AAP 2013 — Wald ER et al. Clinical Practice Guideline for the Diagnosis and Management of Acute Bacterial Sinusitis in Children Aged 1 to 18 Years. Pediatrics 2013

Practice EENT questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.